ArriVent BioPharma, Inc. - COMMON STOCK (AVBP)

CUSIP: 04272N102

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 6 signals
Share change
+922,386
SEC-reported price per share
$26.64
Indexed holders
80
Value change
+$26,598,551
Number of buys
52
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
49,367,935

Security key

04272N102

Report period

Q4 2024

Indexed institutions

80

Top holders

10

Ownership snapshot

Top reported holders of AVBP - ArriVent BioPharma, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F 3/4/5 Highest disclosed value: $105,389,792 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

HHLR ADVISORS, LTD. has the largest disclosed position value at $105.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HHLR ADVISORS, LTD.'s linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $71.14M
Carl L. Gordon $5.52M
HHLR ADVISORS, LTD. $105.39M
Octagon Capital Advisors LP $46.45M
BlackRock, Inc. $45.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F 3/4/5
Company · Director, 10%+ Owner
—
denominator unverified
$71,142,208
3,027,328 shares
— 30 Sep 2024
Carl L. Gordon
3/4/5
Director, 10%+ Owner
—
denominator unverified
$5,524,874
1,513,664 shares
— 30 Jan 2024
HHLR ADVISORS, LTD.
13F
Company
13F
—
denominator unverified
$105,389,792
4,484,672 shares
— 30 Sep 2024
Octagon Capital Advisors LP
13F
Company
13F
—
denominator unverified
$46,445,095
1,976,387 shares
— 30 Sep 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$45,388,348
1,931,419 shares
— 30 Sep 2024
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$43,361,307
1,845,162 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
80
Shares
28,465,885
Indexed holders
80
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 indexed holders
68
Q4 2024 indexed holders
80
Indexed holder difference
12
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .